Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Myoferlin inhibitor YQ-456 shows efficacy in PDX model of colorectal cancer

March 2, 2021

Alofanib shows safety and antitumor efficacy in patients with advanced gastric cancer

March 2, 2021

Amgen discovers kinesin-like protein KIF18A inhibitors

March 2, 2021

Bristol Myers Squibb presents new ROR-gammaT agonists

March 2, 2021

VBL Therapeutics initiates dosing patients in phase II study of VB-111 in rGBM

March 2, 2021

Oncorena cleared to begin phase I/II study in Sweden with orellanine for metastatic renal cancer

March 1, 2021

FDA grants accelerated approval to Pepaxto for relapsed or refractory melanoma

March 1, 2021

Pilot trial investigates magnetic nanoparticles to treat locally advanced pancreatic cancer

March 1, 2021

Mutant GTPase KRAS inhibitors discovered at Beijing Jacobio Pharmaceuticals

March 1, 2021

New cyclin-dependent kinase inhibitors identified at Chengdu Synowest Biotechnology

March 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...